Drug intelligence / Profile preview

Xiao'er Kechuan Granules

Development stage
Unknown
Lead developer
Qingdao Growful Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Xiao'er Kechuan Granules is a Traditional Chinese Medicine (TCM) compound formulation primarily indicated for the treatment of pediatric respiratory ailments, including bronchitis, pneumonia, and cough variant asthma. The formulation is typically based on the classic 'Ma Xing Shi Gan Tang' framework, containing active herbal ingredients such as *Ephedra sinica* (Mahuang), *Prunus armeniaca* (Xingren), *Gypsum fibrosum* (Shigao), and *Glycyrrhiza uralensis* (Gancao), often supplemented with other herbs like *Scutellaria baicalensis* and *Aster tataricus*. It functions as a bronchodilator and anti-inflammatory agent; the ephedrine alkaloids derived from *Ephedra* act as beta-2 adrenergic agonists to relieve bronchospasm, while other components provide antitussive and expectorant effects. Beijing Huikang Century Biotechnology Consulting has been identified as a key developer or regulatory sponsor involved in clinical trials for this formulation, specifically focusing on its efficacy in treating pediatric cough variant asthma.

Brand names
Xiao'er Kechuan Keli
Other names
Xiao'er Kechuan GranulePediatric Cough and Asthma Granules
02

Targets

ADRB2 (β2)

Beyond the preview

Go deeper on Xiao'er Kechuan Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiao'er Kechuan Granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call